<html>
<head>PUBMED IDs for AMN1</head>
<body bgcolor='#C5F0F2'><h1>AMN1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12897782/'>Trans-acting regulatory variation in Saccharomyces cerevisiae and the role of transcription factors.</a> August 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15710324/'>AMN107: tightening the grip of imatinib.</a> February 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16682077/'>Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells.</a> May 10  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16721371/'>AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL.</a> May 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16757427/'>The second generation of BCR-ABL tyrosine kinase inhibitors.</a> June 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16849647/'>The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells.</a> July 20  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17090651/'>Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation.</a> November 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17090638/'>Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.</a> November 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17090634/'>Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density.</a> November 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17090611/'>Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia.</a> November 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17179059/'>New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance.</a> December 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17363509/'>Resistance to c-KIT kinase inhibitors conferred by V654A mutation.</a> March 17  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18314612/'>[Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].</a> March 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18314611/'>[Activating mutations in receptor tyrosine kinases with relevance for treatment of gastrointestinal stromal tumors].</a> March 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18367481/'>Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib.</a> March 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19234339/'>Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.</a> July 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20145140/'>Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.</a> April 8  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22430048/'>Impressive long-term disease stabilization by nilotinib in two pretreated patients with KIT/PDGFRA wild-type metastatic gastrointestinal stromal tumours.</a> August 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22635273/'>Lysine-specific demethylase 2A (KDM2A) normalizes human embryonic stem cell derived keratinocytes.</a> August 29  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23883479/'>Endoplasmic reticulum stress-mediated apoptosis in imatinib-resistant leukemic K562-r cells triggered by AMN107 combined with arsenic trioxide.</a> February 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23883436/'>Genetic and epigenetic analysis of putative breast cancer stem cell models.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23883434/'>Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.</a> December 20  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26207617/'>Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.</a> September 23  2015<br></body></html>
